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EDITORIAL REVIEW
Adaptation of the kidney to protein intake and to urine
concentrating activity: Similar consequences in health and CRF
It has long been known that a high protein intake induces
kidney hypertrophy and enhances renal hemodynamics. Because
of the possible deleterious influence of dietary proteins in chronic
renal failure, a number of investigations in the last decade have
been devoted to the study of changes occurring in renal function
(and morphology) after a protein meal or after chronic alterations
in protein intake. Simultaneously, other studies have investigated
the changes in renal function and morphology induced by chronic
alterations in urinary concentrating activity and/or in circulating
antidiuretic hormone (ADH) level.t It has become evident that
these two conditions share a number of similar consequences
including increased GFR and kidney weight with, in both cases,
preferential enlargement of the renal zone and the nephron
segment most directly involved in the process of urinary concen-
tration.
This article reviews our present knowledge concerning these
two adaptations and emphasizes the relationships between pro-
tein intake on the one hand, and urinary concentration or ADH
on the other. A common mechanism is proposed to explain the
similarity of the changes induced by the two conditions. This
mechanism involves accumulation and recycling of urea in the
renal medulla, which are known to be enhanced both by high
protein intake and by ADH. Finally, the consequences of these
protein/vasopressin-dependent effects on the progression of renal
disease will be discussed.
Adaptation of the kidney to urinary concentration or to protein
intake: Experimental observations
Adaptation to urinary concentration and dilution
Morphologic and functional changes in the kidney in response
to changes in the level of urinary concentrating activity have been
studied in the rat and a few other mammals by inducing chronic
alterations in either the level of fluid intake or the level of ADH.
Several studies have taken advantage of the Brattleboro rat, a
strain in which the gene coding for ADH synthesis is defective and
the hormone cannot be synthesized [1]. These rats suffer diabetes
insipidus (DI), and the circulating ADH level can be easily
manipulated by injections or chronic infusion of AVP or synthetic
V2 agonists. In normal animals, water metabolism can be altered
Rather than "vasopressin," the term "antidiuretic hormone" is often
used in this review since the main effects considered here are dependent
upon the antidiuretic and not the vasoactive actions of this hormone.
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by reducing or increasing water intake, or by infusing AVP or
synthetic V2 agonists in excess of the endogenous level [2, 3].
Until the last decade, studies on ADH action on the kidney had
generally involved the acute effects of the hormone on its target
cells and on the urinary concentrating process. Recently, several
studies have revealed that chronic administration of vasopressin
(in the form of its potent antidiuretic non-pressor V2 analogue,
dDAVP [4]) or chronic stimulation of the urinary concentrating
process leads to very specific adaptations of kidney function and
morphology. These adaptations include: (1) an increase in whole
kidney weight relative to body weight, with one of the renal zones,
the inner stripe of the outer medulla, exhibiting greater hyper-
trophy than other zones; (2) an increase in GFR; (3) accentuation
of the functional and anatomical heterogeneity between superfi-
cial and juxtamedullary nephrons; (4) specific hypertrophy and
increase in transport capacity of the epithelium of the thick
ascending limb of Henle's ioop, restricted to its deepest part
located in the IS; (5) increased reabsorption of calcium and
magnesium in the thick ascending limb, leading to reduction of
the urinary excretion of these two cations; (6) changes in medul-
lary hemodynamics, in the production of some mediators, and in
the chemical composition of the interstitium and epithelial cells.
Renal hemodynamics and renal mass. Chronic alterations in
APR level and in concentrating activity induce marked and
parallel changes in kidney mass and hemodynamics. Brattleboro
rats have smaller kidneys and a lower renal blood flow (RBF) than
normal rats [5]. As shown in Table 1, both their kidney weight
(relative to body weight) and their renal hemodynamics are
markedly increased by chronic infusion of AVP or dDAVP
[6—12]. Relative kidney weight and glomerular filtration rate
(GFR) were also shown to vary in normal rat or mongolian gerbil
as a result of sustained depression or stimulation of urine con-
centrating activity (Fig. 1 and Table 1) [2, 12, 13].
Figure 2 illustrates the influence of chronic vasopressin infusion
on renal hemodynamics in conscious Brattleboro rats [9]. A\TP
increased GFR and renal blood flow (RBF) by 40 to 50%, an
effect that develops slowly (no detectable change was observed
after one hour AVP infusion in the same study) and regresses
when hormone infusion is discontinued (Fig. 2). The influence of
urinary concentrating activity on GFR is also apparent in normal
rats. Four to seven days on an increased water intake, reducing
urinary osmolality from 1,526 to 760 mOsm/kg H20, decreased
mean daily GFR from 1.61 to 1.08 mi/mm (P < 0.001). Con-
versely, chronic dDAVP infusion, raising urinary osmolality to
3,020 mOsm/kg H20, increased GFR to 1.89 ml/min [121 (Table
1). In conscious dogs, RBF was shown to increase significantly
after 36 hours of water deprivation, when usual feeding was
maintained [14].
That RBF and GFR might increase with increasing urinary
concentrating activity and/or vasopressin level has long remained
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Table 1. Influence of chronic alterations in water intake and/or ADH level, or in protein intake, on kidney weight and renal hemodynamics
Kidney weight mg/100 g BWSpecies and conditions
No or
Ref. No or low UCA vs. high UCA low High High/low
.Renal hemodynamics
Unit No or low High High/low
Alterations in urinary concentrating activity (UCA)
5 Brattleboro DI rats vs. Wistar rats 310 400 1.29 RBF, mi/mm X g KW 2.18 0.29 3.80 0.51 1.62
6 Brattleboro DI rats: Control vs. 329 5 388 18 1.18 GFR, ml/min X 100 g BW 0.46 0.01 0.53 0.05 1.15
dDAVP injections
7 Brattleboro DI rats: Control vs. 358 13 441 30 1.23 SNGFR Superficial, nI/mm 34 5 42 6 1.24
dDAVP infusions SNGFR Juxtamed, nI/mm 31 5 59 7 1.90
9 Brattleboro DI rats before vs. after — — — RPF, arbitrary unit 100 150 1.50
chronic AVP infusion GFR, arbitrary unit 100 140 1.40
8 Brattleboro DI rats: Control vs. 386 12 431 31 1.20
dDAVP injections
11 Brattleboro DI rats: Control vs. 555 11 758 42 1.37
dDAVP infusion
10 Brattleboro DI rats: Control vs. 338 8 404 13 1.20
dDAVP infusion
2 Wistar rats: High water intake vs. 457 15 681 16 1.49
dDAVP infusion
12 Spr. Dawley rats: high water intake — — — 14C C1, ml/min in 24 hr 1.08 0.07 1.91 0.09 1.77
vs. dDAVP infusion periods
13 Mongolian Gerbils with or without 359 533 1.49
drinking water
14 Mongrel dogs: control vs. 36 hr water RBF, mI/mm 81.3 3.1 89.0 3.7 1.10
deprivation (with normal food
intake)
Species and conditions
. .
Kidney weight mg/100 g BWLow vs. normal or high protein
Ref. intake Low High High/low
.Renal hemodynamics
Unit Low High High/low
Alterations in protein intake
53 Normal rats: 18 vs. 55% casein 379 473 1.25
54 Normal rats: 18 vs. 67% casein 357 548 1.54
48 Dogs: low vs. high protein — — — GFR after a meal 74.8 135.0 1.80
48 Dogs: low vs. high protein GFR, post absorptive period 37.1 83.8 2.26
42 Munich Wistar rats: 6 vs. 40% casein 374 456 1.22 C1,,, mi/mm X 100 g BW 0.321 0.435 1.36
55 Sprague-Dawley rats: 6 vs. 50% 308 6 407 5 1.32
protein
41 Sprague-Dawley rats: 10 vs. 32% 424 13 497 15 1.17 Ce,, ml/day X 100 g BW 586 19 730 12 1.25
casein
40 Sprague-Dawley rats: 10 vs. 32% 658 15 760 25 1.16
casein
49 Wistar Furth rats: 6 vs. 23% casein — — — C1,,, ml/min 0.76 0.01 1.82 0.17 2.39
49 Wistar Furth rats: 6 vs. 23% casein C1,,, ml/min X 100 g BW 0.54 0.85 1.57
50 Bedouin goats: Wheat stray vs. — — — Ce,, mi/day X kg BW 2260 140 4850 300 2.15
Lucerne hay (0.58% vs. 2.6% N)
51 Ewes: 4.9% vs. 14% protein — — — C1,,, ml/min )< kg BW 1.26 0.30 2.04 0.38 1.62
52 Young healthy humans: 0.64 vs. 1.20 — — — C, mI/mm X 1.73 m2 73.6 23.6 116.4 19.9 1.58
protein/kg/day
Abbreviations are: DI, diabetes insipidus; GFR, glomerular filtration rate; RBF, renal blood flow; SNGFR, single nephron GFR; KW, kidney weight;
BW, body weight; C1,,, inulin clearance; Car, creatinine clearance.
unnoticed, probably because most experimental protocols de-
signed to evaluate the influence of vasopressin on renal hemo-
dynamics explored situations which were too extreme (infusion of
vasopressin after prior induction of water diuresis, or increase in
endogenous vasopressin by severe dehydration) or for too short
periods of time to reveal significant effects [15]. Water diuresis or
prolonged dehydration leads to severe perturbations of fluid
balance which bring into play another set of influences on renal
hemodynamics. We observed that ADH-dependent increases in
GFR can be revealed only within a relatively narrow range of
physiologic regulation, when changes in plasma and extracellular
fluid volumes are prevented or are only moderate, or in chronic
situations such as prolonged reduction (not suppression) of water
intake, which enables a new steady state to be reached [15].
Relative development of the different renal zones and nephron
segments. Concentration-induced hypertrophy of the kidney is not
uniform. The inner stripe of the outer medulla (IS) is far more
hypertrophied than the other zones of the kidney. As a result, the
IS occupies a greater fraction of the total length of the cortico-
medullary axis (Fig. 1), and the nephron segments and vessels
located specifically in this zone become relatively longer than
other structures in the hypertrophied kidney. This provides a
Bankir and Kri.z: Protein intake and urinaiy concentration 9
600
22
0)
14
10
600
400
0
*
• I
I]
HWI CONT AWl ADH
Fig. 1. Influence of urinaiy concentrating activity on kidney size and mor-
phology. Chronic study in Wistar rats. Abbreviations are: HWI, rats with
increased water intake; CONT, control rats; RWI, rats with water
restriction; ADH, rats receiving a constant infusion of dDAVP. The
volume of TAL epithelium per unit tubular length (bottom part) was
measured at different levels along the TAL, including deep (a), mid (b),
and superficial (c) parts of the inner stripe, mid outer stripe (d), and mid
cortex (e). *Significantly different from CONT by ANOVA. Adapted from
[2].
greater length for countercurrent multiplication between thick
ascending and thin descending limbs of Henle's loops and for
countercurrent exchanges between ascending and descending
structures in the vascular bundles, thus resulting in a more
efficient machinery for urinary concentration and in better med-
ullary insulation [16].
In addition to this lengthening, the sustained stimulation of
urine concentrating activity modifies the proportion of thick
ascending limb (TAL) tissue present in the different renal zones.
TAL of well hydrated or control rats exhibit a relatively uniform
Time, days
Fig. 2. Influence of a chronic ADH infusion on urinaiy concentrating
activity (A) and renal hemodynamics (B) in Brattleboro rats with diabetes
insipidus. Note the reversibility of the effects upon cessation of the
infusion. In A symbols are: (O----O) urinary osmolality; (S •)
urinaly flow rate; in B: (O----O) plasma flow rate, (S 5) GFR; ()
vasopressin infusion. Adapted from [9]; used with permission.
volume of epithelium from the depth (IS) to the surface (cortex).
In contrast, that of rats with increased sollicitation of urinary
concentrating processes is markedly enlarged in the IS and
thinned in the cortex (Fig. 1) [2]. Taking into account both the
elongation of the IS and the thickening of the medullary TAL
(MTAL), total TAL tissue per rat increased markedly with
increasing urinary concentration, from 12.9 to 21.7 mm3/100 g
body wt, and the fraction of TAL epithelium located in the IS
grew from 37 to 65% of total TAL epithelium volume per
nephron (in rats with increased water intake and rats receiving
ADH infusion, respectively) [16]. Most of the MTAL hypertrophy
results from enlargement of pre-existing cells and not from cell
proliferation. In the enlarged cells, mitochondrial volume and the
area of the basolateral membrane increase homogeneously in
proportion to cell volume. The incidence of binucleated cells (a
sign of intense metabolic activity) in the wall of the MTAL is
markedly increased [11].
The MTAL hypertrophy is accompanied by parallel increases in
hormone-stimulated adenylate cyclase activity, Na-K-ATPase ac-
tivity [8], and electrolyte transport capacity [17] (Table 2). The
changes in enzyme activities per unit length of tubule in the
medullary TAL are proportional to the hypertrophy, suggesting
that they result from an increase in basolateral membrane surface
area rather than from an increase in the density of enzyme
molecules in this membrane (Table 2). The parts of the TAL lying
in the outer stripe and in the cortex do not exhibit changes in
volume or enzyme activities; if anything, these factors tend to be
reduced (Fig. 1) [2, 8, 11, 18].
The "diluting segment" of the amphibian kidney (equivalent to
the mammalian TAL [19]) adapts to changes in ambiant osmola-
lity very similarly to the MTAL in rats. Salamanders conditioned
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Table 2. Influence of alterations in water intake and/or ADH level, or in protein intake, on enzyme activity and transport in specific nephron
segments
Ref. Species and conditions Parameter
Ratios high/low in
nephron segments
MTAL CTAL CCD MCD
Alterations in urinary concentrating activity
8 Brattleboro DI rats: dDAVP-treated vs. controls ADH-dependent ADC
Glucagon-dependent
ADC
Na-K-ATPase activity
Volume of epithelium
ADH-dependent ADC
Glucagon-dependent
ADC
Na-K-ATPase activity
per unit lengthU
"""U
per unit
volume
"""
"
1.73a
1.76a
1.69"
166a
1.02
1.13
1.11
0.55a 0.83 0.95
0.74a Q44a 0.22a
1.26 2.17a 1.19
17 Brattleboro DI rats: AVP-treated vs. controls Transepith. potent.
duff.
Chloride flux
Volume of epithelium
per unit length
"""U
2.40"
2.10"
lisa 0.99 1.01 1.00
18 Gerboa, dehydrated vs. normally hydrated Na-K-ATPase activity
Volume of epithelium
Na-K-ATPase activity
20 Salamander living in pond water vs. distilled Transepith. potent.
water duff.
Na-K-ATPase activity
Volume of epithelium
Alterations in protein intake
40 Sprague-Dawley rats: 32% vs. 10% casein Tubule radius
Na-K-ATPase activity
per unit length
U
per unit
volume
per unit length
"""
"""
per unit length
1.30c
1.27"
0.98
1.01 1.46" 1.06
1.02 1.43 1.07
1.48a
I.
1.82a
1.28
diluting segment
MTAL
Inner stripe
l.37'
l.491U
MTAL Loop of Henle
Outer stripe (= MTAL + CTAL)
1.10
0.96
43 Sprague-Dawley rats: 40% vs. 6% casein NA reabs. in loop of
H. (micropuncture)
Na-K-ATPase activity per unit length 187b
122b
57 Sprague-Dawley rats: 40% vs. 6% casein Na reabs. in loop of
H. (micropuncture)
140b
For each parameter, the table shows the ratio of values found in "High" vs. "Low" condition.
ap < 0.05; bp < 0.01; C < 0.001
Abbreviations are: ADC, adenylate cyclase activity; H, Henle; MTAL and CTAL, medullary and cortical thick ascending limb, respectively; CCD and
MCD, cortical and medullary collecting duct, respectively.
to live in distilled water instead of pond water exhibit a larger
diluting segment, together with increased Na-K-ATPase activity,
transepithelial potential difference, and ouabain binding [20]
(Table 2). This adaptation helps conserve solutes by enhancing
the capacity of the kidney to dilute urine. In mammals, the hyper-
trophy and enhanced activity of the TAL also increase the urinary
diluting power. This is illustrated by the fact that the diabetic
condition of Brattleboro rats becomes worse after cessation of
chronic treatment with ADH than that of never treated DI rats
(urine osmolality "'"80 mOsm/kg H20 vs 170 in never treated DI
rats, and urinary flow rate '""125 m1124 hr X 100 g body wt. vs. 65)
[211. This changes were seen to last for several weeks (M.M.
Trinh-Trang-Tan, N. Bouby and L. Bankir, personal observation).
The impaired solute reabsorption by the thick ascending limb in
ADH-deficient rats lead to an increased delivery of NaCl to the
next nephron segment, the distal convoluted tubule (DCT) [22,
23]. As a consequence of this increased load, Na and Cl transport
in this segment is permanently enhanced, resulting in thickening
of the epithelium, increase in the number of cells per cross
section, and elongation [24]. Chronic treatment with dDAVP,
increasing transport in the ioop of Henle and thus decreasing the
load to the DCT, was followed by a decrease in epithelium height
and number of cells per cross section, to values close to those seen
in normal rats [24].
Internephron heterogeneity. The above-mentioned urinary con-
centration-dependent increases in kidney weight and in GFR are
unequally distributed among nephrons. In most mammals, jux-
tamedullary nephrons have a larger glomerulus and a longer
proximal tubule, and exhibit a higher single nephron filtration rate
(SNGFR) than superficial nephrons [25]. This normal heteroge-
neity is absent in Brattleboro rats and can be restored to almost
normal by chronic ADH treatment [6, 7]. Alterations in urinary
concentrating activity were also shown to influence nephron
heterogeneity in normal rats [2]. Additional experiments in mice
with nephrogenic DI showed that the usual nephron heterogene-
ity does not depend on vasopressin per se, but rather on the
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Urine osmolality, mOsm/kg H20
Fig. 3. Influence of urinaiy concentrating activity on papillaiy plasma flow
rate (PPF) measured by the albumin accumulation technique (note the log
scale for the abcissa). Symbols are: (0) DI, homozygous Brattleboro rats
with diabetes insipidus; (A) HZ, heterozygous Brattleboro rats (controls
for the DI); (0) DI rats receiving AVP or dDAVP acutely (30 mm); (0)
control Wistar rats; () Wistar rats dehydrated for 2 days; (•) DI rats
receiving dDAVP chronically (5 days). Each point is the mean of 6 to 15
rats. A group of Wistar rats was dehydrated. Adapted from data in [10];
used with permission.
efficient operation of the urinary concentrating processes. These
mice also exhibit significantly reduced nephron heterogeneity,
although they have normal (or even increased) circulating vaso-
pressin levels [26].
Other urinary concentration-induced changes. The hormonal
regulation of medullary hemodynamics is still incompletely un-
derstood. The renal medulla includes several different vascular
compartments and most available techniques cannot investigate
them all adequately. Most studies dealing with the influence of
ADH on "medullary" blood flow actually concern only the tip of
the papilla, that is, the most extreme part of the medulla, and
provide no information on the influence of this hormone on blood
flow to the outer medulla, where the active, energy-demanding
steps of the urinary concentrating process take place [271.
Homozygous Brattleboro rats with DI exhibit a high papillary
plasma flow rate (PPF) compared to heterozygous rats of the
same strain or to normal Wistar rats (461 26 vs. 270 16 l
min1 g1, P < 0.001). After chronic dDAVP administration,
PPF decreases in proportion to the concomitant increase in urine
osmolality (Fig. 3) [10]. This influence does not seem to depend
on the vascular effects of vasopressin since a non-pressor agonist
is able to induce these changes [10].
The availability of ADH has been shown to exert a marked
influence on the urinary excretion of divalent cations, calcium and
magnesium [21]. DI rats exhibit an abnormally high excretion of
these cations which is dramatically lowered by chronic ADH
infusion, without altering that of sodium or potassium [21].
Micropuncture and microperfusion experiments have localized
these effects to the cortical thick ascending limb [22, 28].
Finally, the prolonged absence or presence of ADH has been
shown to influence (indirectly in some cases) other aspects of
renal function including prostaglandin synthesis [29, 30; reviewed
in 31, 32], renin-angiotensin system [33, 34], composition of
medullary interstitial tissue [35], and accumulation of osmolytes in
renal cells [reviewed in 36].
Adaptation to protein intake: Similarities with the adaptation to
urinary concentration
That high protein (HP) intake increases renal hemodynamics
and hypertrophies the kidney has been known for decades. The
mechanisms responsible for these effects are, however, still not
well understood in spite of intense research stimulated by the
desire to understand why and how the level of protein intake
influences the progression of chronic renal diseases. Obviously,
several factors are involved simultaneously and/or successively.
The aim of this review is to analyze specifically the possible
contribution of factors related to protein-induced changes in urea
3000 5000 excretion and in water balance. Because of the role played by urea
in the process of water conservation, we think that these factors
should bring essential clues to our understanding of the mecha-
nisms by which the kidney adapts to changes in the level of protein
intake. As will be described below, several findings point to a
major role of ADH and urinary concentrating processes in
inducing the protein-induced changes in renal function and
anatomy. A number of other biochemical, humoral, and nervous
factors which are certainly also involved in the renal adaptation to
protein intake will not be addressed here. They have recently been
reviewed by other authors [37—39].
A striking similarity is observed between protein- and concen-
tration-induced changes in renal function and morphology, as
illustrated in Figure 4. This figure displays the results of several
independent studies performed either by varying ADH and/or
water availability on the one hand [2, 8, 12, 17], or the level of
protein intake on the other [40—43].
The influence of the level of protein intake on kidney weight
and renal hemodynamics is well documented (Table 1) [41—52].
Typically, kidney weight relative to body weight is about 20 to 50%
greater in animals fed a protein-rich versus a protein-poor diet
[40—42, 53—55] and the kidney enlargement is roughly propor-
tional to the protein content of the diet [44]. The effect of HP
intake is cumulative with that of many other stimuli for renal
growth [56].
Most interesting is the observation that the protein-induced
hypertrophy exhibits the same intrarenal pattern as that induced
by ADH and stimulation of urinary concentrating activity (Fig. 4).
The IS is lengthened along the cortico-medullary axis by 54%
versus only 12% for the kidney as a whole [411. This preferential
increase of the IS seems specific to conditions when the stimulus
for kidney enlargement is linked to protein intake and/or urinary
concentration, since in other situations involving an increase in
kidney weight such as normal growth with age or compensatory
hypertrophy, all kidney zones enlarge in fairly equal proportions
[411.
Within the IS, the MTAL hypertrophies about 50% more than
expected from the overall increase in kidney mass. This hypertro-
phy is more pronounced in the earliest part of this segment and is
not observed in the outer stripe or in the cortex [411, a situation
very similar to that described after chronic stimulation of urinary
concentration. In vivo micropuncture and ioop microperfusion
experiments have provided strong evidence that the transport
activity of the TAL is markedly increased after high protein intake
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[57], a change that is paralleled by an increase in Na-K-ATPase
activity per unit tubular length in the MTAL [40, 43] (Fig. 5 and
Table 2).
The parallelism between protein- and concentration-induced
changes also concerns internephron heterogeneity. High protein
feeding accentuates the difference in glomerular volume between
superficial and juxtamedullary nephrons [41]. It may be reason-
ably assumed that the difference between superficial and deep
nephron SNGFR is also enhanced, although such measurements
are not available. The finding by Seney and Wright of a higher
increase in whole kidney GFR than in superficial nephron GFR
(29 vs. 21%, respectively) is compatible with this view [58].
Urea excretion and water conservation: Crucial factors in the
vasopressin- and protein-induced changes in renal function
Vasopressin and urea
No active transport of urea seems to be involved in the urinary
concentrating mechanism [59]. Nonetheless, urea is concentrated
to a very high extent in urine with respect to plasma and plays a
crucial role in the urinary concentrating mechanism. By its
accumulation in the inner medulla (IM), urea contributes to
enhance the osmotic pressure gradient able to subtract water from
the collecting ducts (CD) [59], thus explaining why urea has the
unique property of inducing "an economy of water in renal
function" as stated by Gamble et al sixty years ago [60]. Note that
this economy occurs only within certain limits of the urea/non-
urea solute ratio in the urine [61].
Urea accumulation in the IM is critically dependent on the V2
effects of ADH on the CD in two ways. (1) By increasing water
permeability in the cortical and outer medullary CD, ADH favors
urea concentration in the lumen of the CD. (2) In the terminal
part of the IMCD, ADH enhances the permeability of the
epithelium to urea, thus enabling urea (concentrated upstream) to
diffuse into the papillary interstitium [59, 621. In the absence of
ADH (after induction of intense water diuresis or in Brattleboro
rats with DI), the accumulation of sodium in the IM is close to
normal, wheras that of urea is totally abolished [63, 64]. Upon
reintroduction of ADH, urea accumulation in the IM is a rela-
tively slow process, and several hours (after water diuresis) or days
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Fig. 4. Similarity of the effects induced in
kidney morphology and function by chronic
alterations in either urinaiy concentrating
activity (ADH vs. 11W!) or protein intake (HP
vs. LP). Abbreviations are: HWI, Brattleboro
rats with DI or Wistar rats with increased
water intake (that is, low urinary
concentrating activity); ADH, Brattleboro or
Wistar rats receiving a constant infusion of
dDAVP; LP, low protein diet (6 or 10%
casein); HP, high protein diet (32 or 40%
casein). Adapted from [2, 8, 12, 17] for HWI/
ADH, and [40—43] for LP/HP.
LP
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HP
Fig. 5. Influence of protein intake on Na-K-A TPase activity and epithelium thickness in Sprague-Dawley rats ftd 10 or 32% casein diets (LP and HP,
respectively). Longitudinal sections of kidneys showing the inner stripe of the outer medulla after a histochemical reaction revealing ATPase activity. The
density of the enzyme activity per unit cell surface area in the thick ascending limbs was unchanged but the size of the cells, the epithelium volume and
hence the Na-K-ATPase activity per unit length of tubule (as well as sodium chloride reabsorption, see text) were markedly increased. Bars = 100 m.
Reproduced from [40].
(after diabetes insipidus) are required to reach maximal urinary
osmolality [64—661.
Actually, urea tends to be continuously washed out from the IM
by the blood flowing in the venous, ascending vasa recta. Coun-
tercurrent exchanges between ascending and descending vasa
recta limit this wash-out. In addition, a complex recycling route
brings back part of this urea to the IM as follows. In the outer
medulla, urea diffuses by countercurrent exchange from ascending
vasa recta into the descending branch of the nephrons (thin
descending limbs of short looped nephrons and possibly pars recta
of all nephrons). Urea is then concentrated in the lumen of the
distal nephron by water abstraction and returns to the IM by
diffusion from the terminal CD. This recycling process renders
urea accumulation in the IM more efficient and thus improves
urinary concentrating ability. However, it has two major conse-
quences which have not been given much attention in the last
decades, but might be of great importance in understanding the
adaptation of the kidney to chronic high urinary concentration.
Consequences of the vasopressin-dependent intrarenal urea recy-
cling. The first consequence is that vasopressin-dependent urea
recycling markedly reduces the efficiency of urea excretion since it
subtracts from the urine some of the urea flowing in the terminal
CD and reintroduces it into the nephron. Moreover, vasopressin-
dependent water reabsorption in cortical and medullary CD slows
the urine flow rate and increases the transepithelial gradient of
urea concentration, two factors which increase passive urea
reabsorption along the whole CD [67, 68]. These combined effects
markedly reduce the fractional excretion (FE) of urea. At high
urinary flow rates, about 60% of the filtered urea is excreted in the
urine whereas at low urinary flow rates, FEurea falls to only 20%
[68]. As a result, three times more urea needs to be filtered at low
than at high urinary flow rates in order to ensure the same urea
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Table 3. Influence of papillectomy on kidney weight (KW) and glomerular filtration rate (GFR)
Ref. Rat strain and protocol Parameter Control Papillect. Pap/Cont
74
75
73
Wistar rats. anesthetized, SPX, 2—8 weeks
Wistar rats, anesthetized, SPX, 3—6 weeks
Wistar rats, anesthetized, CPX, 5—7 weeks
GFR, mI/mm (1 K)
KW, g
GFR, mI/mm X kg BW (1 K)
KW, g
GFR, mI/mm X 100 g BW
1.06 0.22
1.50 0.27
3.03 0.24
1.23 0.05
1.25 0.09
0.58 0.18
1.03 0.26
1.69 0.16
1.03 0.04
0.80 0.13
0.55
0.69
0.56
0.83
0.64
72
71
SHR rats, anesthetized, CPX, 12 weeks
Wistar rats, anesthetized, CPX, 6—10 days
GFR, 1.d/min X 100 g BW
KW, per unit BW
GFR, mi/mm (sum of 2K)
701 48
2.1 0.1
459 30
1.4 0.1
0.65
0.90
0.67
76 Wistar rats, anesthetized, CPX, 24 hrs GFR, ml/min (sum of 2 K) 1.97 0.14 1.16 0.14 0.59
77 Sprague-Dawley rats conscious, CPX, 2 days GFR, mi/mm (sum of 2 K) 2.52 0.14 2.13 0.09 0.84
70 Wistar rats conscious, CPX, 24 hrs GFR, j.ti/min X 100 g BW 895 69 584 26 0.65
Abbreviations are SPX, unilateral surgical papillectomy vs. contralateral normal kidney; CPX, chemical papillectomy with bromoethyleneamine vs.
control group; K, kidney; BW, body weight.
excretion. In this context, the increase in renal hemodynamics
seen after sustained stimulation of urinary concentrating activity
(reviewed above) contributes to increasing the amount of urea
filtered. As a result, plasma urea concentration increases less than
would be expected from the ADH-dependent reduction in FEurea
[69].
The second consequence is that the variable intensity of the
urea recycling process probably results in wide variations in the
concentration of urea flowing in the thick ascending limb, and
thus in the transepithelial urea concentration gradient in this
segment. As deduced from micropuncture studies of the accessi-
ble early distal tubule, the tubular fluid-to-plasma urea concen-
tration gradient in the late TAL probably varies between 3 and 10,
according to the level of urea recycling. With high urea recycling,
urea may account for as much as half of the solutes present in late
TAL fluid. To our knowledge, the possible consequences of such
large variations in luminal concentration of urea on TAL function
have never been investigated. We recently proposed a novel
hypothesis explaining how vasopressin-dependent urea recycling
and the resulting increase in urea concentration in the TAL lumen
could indirectly influence the tubuloglomerular feedback signal
(TGF) and thus alter GFR [69]. In brief, urea, acting as an
osmotic buffer in the lumen, could reduce an osmotically driven
water leakage from the TAL and thus could enable a lower NaC1
concentration to be reached in the fluid passing by the macula
densa.
In this hypothetical mechanism, vasopressin-dependent urea
movements within the kidney would be responsible for an increase
in renal hemodynamics. This original concept is supported by the
following observation. A number of independent studies all show
that papillectomy (surgical removal or chemical destruction of
inner medullary tissue), which reduces urinary concentrating
capacity and increases urinary flow rate, is followed by a dramatic
fall in both GFR and kidney weight (Table 3) [70—77]. These
reductions do not seem to be a mere consequence of diminished
nephron number since no more than 10 to 15% of all nephrons
have a long loop reaching the papilla and are thus likely to
degenerate after papillectomy. Moreover, hyperfiltration and
hypertrophy of non-damaged superficial nephrons could easily
bring renal function and weight back to normal, as observed after
partial nephrectomy. Papillectomy obviously compromises urea
recycling by suppressing or damaging the terminal CD where the
initial step of this recycling occurs. It may be assumed that the
absence of urea recycling (1) permits an efficient urea excretion
(high fractional excretion), and (2) reduces the concentration of
urea in the TAL lumen thus possibly abolishing the putative
urea-dependent influence on TGF. This could explain the low
GFR, reminiscent of that seen in Brattleboro rats or in normal
rats where urinary concentrating activity and urea recycling are
reduced by a chronic increase in water intake (Table 1).
If it is confirmed that vasopressin and the resultant intrarenal
urea recycling indeed induce a chronic hyperfiltration, the natural
tendency to produce hypertonic urine has a high cost for the
kidney. The price paid for this efficient water conservation process
is not limited to the energy spent in concentrating the daily load
of osmoles (involving active sodium reabsorption in the thick
ascending limb) but also includes consequences on the glomerular
filter of sustained high pressure and flow, and the energy spent in
reabsorbing the extra solutes filtered. This favorable adaptation
in terms of evolution could thus have a deleterious influence in
chronic renal failure.
Vasopressin action on liver metabolism. It is worth mentioning
here another, intriguing, aspect of the vasopressin-urea relation-
ships. Hepatocytes are well equiped with vasopressin V1 receptors
[78] (the liver has even been used for purification and cloning of
this receptor [79]). In vitro, hepatocytes respond to vasopressin by
an increased metabolic activity including enhanced gluconeogen-
esis and ureagenesis, effects that are additive to those of glucagon
[80—83]. The physiologic relevance of vasopressin action on liver
metabolism has not yet been established in vivo. However, if these
effects occur for physiologic levels of the hormone, it is tempting
to assume that vasopressin, in addition to enhancing intrarenal
urea recycling, might actually also increase the amount of urea
delivered by the liver to the kidney.
Protein intake, urea, and vasopressin
An increase in protein intake above the minimum requirement
for maintaining nitrogen balance will induce a roughly parallel
increase in the excretion of urea, the major end-product of protein
catabolism. Since urea is far more concentrated in urine than
in plasma (20- to 50-fold in humans, several hundred-fold in
rodents), the "osmotic work" that the kidney must accomplish in
order to excrete urea in a reduced amount of water increases
in proportion to the increase in protein intake. Figure 4 shows that
free water reabsorption rises with protein intake as it does after
ADH administration [84]. The striking similarity of the changes
induced in kidney function and morphology either by a high
protein diet or by ADH infusion strengthens the notion that ADH
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% Casein in diet
Fig. 6. Influence of protein intake on solute excretion (dotted line) and free
water reabsoiption (solid line). Data from two studies in Sprague Dawley
rats are combined (0, [411;S, [91]). Urea accounts for the largest part of
the increase in solute excretion with increasing protein intake. Free water
reabsorption (that is, the amount of water that the kidney reabsorbs to
concentrate urinary solutes at the observed osmolality) is also increased in
parallel. Reproduced from [84]; used with permission.
and/or the consequences of its action on the kidney play a decisive
role in the renal response to dietary proteins. Three relevant
questions may be considered. How does the level of protein intake
and the ensuing changes in urea excretion influence water metab-
olism and the kidney's "osmotic work" (as defined by Addis [85,
86])? How does the kidney of ADH-deficient Brattleboro rats
react to high protein intake? Do changes in protein intake affect
circulating ADH level?
Relationships between protein intake, and urea and water excre-
tions. As recalled above, urea concentration is permitted by the
recycling of urea and its accumulation in the renal medulla. The
intensity of urea accumulation in the medulla, and hence of urea
concentration in the urine, critically depends (1) on the level of
ADH and (2) on the amount of urea available. Medullary urea
accumulation is impaired when ADH is depressed, as in water
diuresis [63], or absent, as in Brattleboro rats [641, and is restored
by a few days of ADH infusion (this restoration requires a longer
time when ADH is not infused continuously but is given as daily
injections [7, 87]). On the other hand, medullary accumulation of
urea is reduced when the amount of urea to be excreted is low.
This explains why urinary concentrating ability is impaired by low
protein intake and protein malnutrition [88]. Conversely, high
protein intake, increasing urea delivery to the kidney, increases
maximum urinary concentrating ability [41, 89, 901. Note that even
on ad libitum fluid intake (that is, when no attempt is made to
induce maximum concentrating capacity), the kidney's spontane-
ous concentrating activity is also significantly enhanced by a high
protein diet, as illustrated in Figure 6 [41, 91].
We observed that high protein diet increases osmolar excretion
and the reabsorption of free water (T'H2O) in a very parallel
fashion (Fig. 6). This means that the kidney reabsorbs more water
during high than during low protein intake, in order to concen-
trate a larger amount of urea. Maintaining the medullary osmotic
pressure gradient in the face of an increased solute excretion
obviously requires a more intense transport activity in the
nephron segment involved in the separation of salt from water,
that is, the TAL. Therefore, the increase in TCH2O seen on a high
150 protein intake is likely the result of an equivalent increase in
reabsorptive work of the TAL. Knowing this relationship, the
120 enhanced sodium chloride reabsorption measured in the ioop of
Henle [57], and the selectively greater hypertrophy [41] and
90 enhanced Na-K-ATPase activity [40, 43] observed in the TAL onE a high protein intake (Fig. 5) are obviously related to the in-
creased power necessary for enhancing free water reabsorption in60 I the face of an increased load of urea to be excreted in a
concentrated urine. The mechanisms by which ADH uld di-
30 rectly of indirectly influence TAL function will be discussed later
in this review.
0 Besides the possible contribution of ADH, it is interesting to note
that amino acids and glucagon, known to increase their concentra-
tion in the blood after a protein meal, could also contribute to
enhancing both GFR and urinary concentrating activity by influenc-
ing TAL transport. First, certain amino acids have been shown to
exert a vasodilatory effect on the kidney while improving urinary
concentrating ability and preservation of TAL integrity during in vitro
perfusion of isolated rat kidneys [92—96]. Second, in anesthesized
dogs, i.v. infusion of the amino acid glycine was shown to increase
GFR together with a marked increase in the metabolic rate of the
outer medulla, likely ascribable to an increase in active transport in
the TAL [97]. Third, glucagon has been shown to simultaneously
enhance GFR and urinary concentrating ability even when ADH was
maintained at a constant level [98, 99]. The latter effect most
probably results from direct stimulation by this hormone of sodium
chloride transport in the TAL [100]. In agreement with this possib-
lity, glucagon was shown to decrease the intensity of tubuloglomeru-
lar feedback [101] in a way similar to that observed after high protein
intake [57].
Influence of protein intake on the kidney in the absence of ADH.
Bouby and coworkers [102] showed that, in Brattleboro Di rats (that
is, in the absence of ADH) the changes in renal function and
anatomy usually induced by high protein intake are greatly reduced
(modest increase in GFR) or even absent (no change in kidney mass
or in the relative height of the inner stripe of the outer medulla; Fig.
7). This suggests that ADH (or the operation of the concentrating
process) is necessary for full manisfestation of the effects of high
protein intake on the kidney. On the other hand, Fernandez-
Repollet et al [103] also studying the influence of protein intake on
GFR and kidney weight in Brattleboro DI rats, concluded that these
effects did not depend on ADH. However, the unequal growth of the
rats in different groups fed different protein diets has not been taken
into consideration in their study. Factoring GFR and kidney weight
by body weight markedly reduces the observed differences [103], thus
showing, as in Bouby et al's study that protein-induced changes are
weakened in the absence of ADH.
Worthy of interest is the observation that, contrary to what
occurs in normal rats with ADH, HP diet in Brattleboro DI rats
induced no change in free water clearance or in the urine-to-
plasma urea concentration ratio, in spite of the expected change in
absolute urea excretion (Fig. 7). An acute injection of ADH
restored a significant difference in the capacity to reabsorb free
water between HP- and LP-fed DI rats, likely attributable to the
greater availability of urea for ADH-induced urea accumulation
and recycling in the medulla in HP-fed rats [102]. These observa-
tions underline the interdependence of urea and ADH in enabling
the kidney to spare water.
The effects of proteins in normal rats are also blunted if high
protein intake is associated with increased water intake intended
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Fig. 7. Influence of protein intake on the
kidney in rats with (Sprague Dawley) or without
antidiuretic hormone (homozygous Brattleboro
rats with central diabetes insipidus). Although
high protein intake induced comparable
enhancement of urea excretion (A) in the two
strains of rats, kidney weight (B), relative urea
concentration in urine with respect to plasma
(C, U/Purea), and free water clearance (D,
CH2O) did not change in the rats that were
unable to concentrate their urine (*P < 0.05
or less vs. corresponding LP group) (adapted
from [40, 41, 102]).
Fig. 8. Influence of protein intake on plasma
ADH concentration. A. Chronic effects in
healthy subjects on low or high protein intake
for several days; reproduced from [1061. B.
Acute effects in healthy subjects studied
before (control) and during 3 hours after
ingestion of a protein meal
(* and ** = P < 0.05 and 0.01, respectively,
vs. control period); adapted from [108].
to reduce urinary concentrating activity [104]. Conversely, they
are intensified when ADH infusion is combined with high protein
diet [51]. All these observations strongly suggest that ADH is
involved—or at least plays a permissive role—in the protein-
induced changes in GFR and kidney mass.
Influence of protein intake on plasma ADH concentration. Little
information is available regarding the influence of protein intake
on vasopressin plasma level. Changes in this hormone could,
however, be suspected since the kidney's concentrating activity is
obviously increased by a higher protein intake, as explained above.
In 1964, using an ADH bioassay, Little and Radford reported that
high protein intake in rats increased plasma antidiuretic activity in
a chronic fashion, that is, even when measured at a distance from
the last meal [105]. More recently, an investigation in normal
volunteers showed that several days on a high protein intake
increase plasma vasopressin 2.6-fold (Fig. 8) [106]. We also
observed a higher AVP in rats fed 32 versus 10% casein diets (N.
Bouby, L. Bankir and D. G. Bichet, unpublished results).
Two investigations in humans show that vasopressin plasma
level increases about twofold in the two to three hours following
a single protein meal (Fig. 8). Urine osmolality also increases
simultaneously [107, 108]. The changes in plasma vasopressin and
urine osmolality that occur in everyday life after ingestion of a
protein meal are probably even greater than revealed by these
600
>
400
200
0
80
0
—80
>
E
LPHP LPHP
20
>
10
0
200
100
0
A
10 —
8
6-
4-
2-
0
Sprague
Dawley
(AVP)
2.5
D CH2O
vi
LPHP LPHP
Sprague
Dawley
(AVP)
Brattleboro
with DI
(NoAVP)
B
**
. *
0
Control 1 hr
I
2 hr 3 hr
Brattleboro
with Dl
(N0AVP)
P<0.05
2.0
1.5
1.0
0.5
Low High
Bankir and Kriz: Protein intake and urinaiy concentration 17
studies since they were carried Out in a state of mild [108] or high
[107] water diuresis achieved by frequent—non physiologic—fluid
ingestion during pre- and post-meal hours.
The study of Hadj et a! showed that the increase in plasma
vasopressin seen after a meal strictly follows an increase in plasma
osmolality (observed in spite of periodic hydration) [108]. Because
plasma amino acid concentration may increase by several mmol/
liter after the ingestion of a protein meal [109, 110], and because
these amino acids probably exert an osmotic influence on sensitive
cells responsible for vasopressin release, it may be assumed that
an increase in the release of this hormone is a normal event during
postprandial hours when the meal is rich in proteins. To our
knowledge, the influence of alterations in plasma amino acid
concentration on vasopressin release has not been studied.
Possible common mechanism(s) responsible for adaptation of
the kidney to urinary concentration and to protein intake
On the whole, the observations reviewed in the preceding
sections have established (1) that the protein-dependent changes
in GFR, kidney weight, and free water reabsorption are strikingly
similar to those induced by chronic stimulation of urine concen-
tration; (2) that ADH is required for the protein-dependent
changes in renal function and morphology; and (3) that ADH
plasma level is elevated by acute protein ingestion and by chronic
high protein intake. These observations strongly suggest that
protein- and concentration- (ADH) induced changes in kidney
function and morphology share a common mechanism(s) and/or
that ADH participates to a significant extent in the protein-
induced effects.
These observations, however, do not reveal the common step
that could initiate the changes induced by dietary proteins and/or
ADH. Even if ADH secretion increases after protein ingestion, its
contribution by a direct vasoactive effect on glomerular arterioles
can be ruled out as the possible cause for the increase in GFR
since (1) the change in GFR requires several hours and thus does
not likely result from acute modulation of vascular tone [9], and
(2) dDAVP, a nonpresssor analogue of AVP, induces this in-
crease in renal hemodynamics [7, 111].
Increased transport in the TAL
Because high protein intake increases urinary concentrating
activity and induces a more prominent enlargement and increased
activity of the nephron segment most directly involved in urinary
concentrating activity, as does chronic stimulation of urinary
concentration by vasopressin, it is tempting to imagine that an
early event, common to both conditions, is stimulation of active
transport in the TAL. The results of Seney and Marver show that
the enhancement in loop NaC! reabsorption precedes the increase
in medullary mass and could thus be the cause, rather than the
consequence, of MTAL hypertrophy [43].
Actually, the TAL is ideally suited for exerting an effect on both
GFR and urinary concentration since (1) it is located just prior to
the macula densa and its fluid is thus susceptible to influencing the
TGF control of GFR, and (2) it generates, by its active NaC1
reabsorption, the "osmotic work" responsible for building up and
maintenance of the osmotic pressure gradient in the medulla (Fig.
9). Whole kidney enlargement would follow the chronic increase
in GFR in order to adapt the reabsorptive capacity of the kidney
to the higher level of filtration [56] with, however, preferential
hypertrophy of the renal zone (IS) and nephron segment (TAL) in
which the initiating process took place. This scheme is compatible
with experimental data of Seney, Persson and Wright showing that
the mechanism responsible for the rise in GFR during high
protein intake involves depression of the TGF due to a more
intense reabsorption in the loop of Henle (in the TAL) and the
subsequent lowering of NaC1 concentration at the macula densa
[57].
If stimulation of TAL transport seems a very likely common
step in the protein- and concentration-induced changes in renal
hemodynamics and size, the stimulus that initiates this increased
transport remains unknown. A few possibilities will be discussed
below.
Direct effect ofADH and/or glucagon on the TAL?
Vasopressin and glucagon stimulate adenylate cyclase activity
[112] and solute reabsorption in the TAL [22, 100, 113, 114].
Protein (or amino acid) ingestion stimulates glucagon [115, 116]
and vasopressin (see above) secretion. It is thus logical to assume
that, during chronic high protein feeding, these two hormones
could contribute to enhancing TAL transport by their direct effect
on this nephron segment. The significant increase in urinary
osmolality and/or in free water reabsorption seen after infusion of
physiological amounts of glucagon in rats favors this possibility for
glucagon [98, 99, 117]. In contrast, a direct influence of vasopres-
sin on TAL transport is probably not involved since the plasma
level of this hormone required for stimulating this transport in the
rat is relatively high [118] and since the functional consequences
of vasopressin influence on TAL are detectable in vivo only after
two days of water deprivation [119]. Nonetheless, because vaso-
pressin increases concommittantly with glucagon after a protein
meal, additive effects of the two hormones on TAL transport
cannot be ruled out.
Apart from a possible direct hormonal influence, the morpho-
logical and functional changes of the TAL seem to result from a
more complex sequence of events involving alterations in the
composition of the tubular fluid and/or of the peritubular envi-
ronment. The following examples demonstrate the influence of
physico-chemical factors (independent of changes in hormonal
concentrations) on epithelium transport and development. (1) Im-
pressive structural and functional adaptation occurs in the
salamander diluting segment when the solute conservation capacity
of animals is challenged by immerging them in distified water [20].
(2) A significant fall in enzymatic activity and cell mass is observed in
a blinded intestinal loop whereas compensatory increases are seen in
the next gut segment in which food transit was maintained and which
had become more proximal [120]. Since the blood supply and thus
the same hormonal environment were maintained in both loop
segments, their opposite adaptations obviously resulted from changes
in luminal delivery and not from possible alterations in circulating
hormones [120]. (3) A load-dependent increase in cellular volume,
enzymatic activities, and active electrolyte transport have been
observed in the distal convoluted tubule, in experimental conditions
in which the function of the preceding segment was blocked and the
hormonal environment maintained constant [24, 121, 122]. These
observations suggest that changes in luminal delivery might be the
major cause of the protein- and ADH-induced increases in TAL
function.
As explained earlier, the changes induced by high urinary
concentrating activity or by high protein intake do not concern the
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Fig. 9. Proposed sequence of event explaining the changes seen in renal anatomy and function after stimulation of urinaty concentrating activity or high protein
intake. The first, and well demonstrated effect in both situations is the hypertrophy and increased transport activity of the medullaiy thick ascending limb
(MTAL). These changes can adequately explain the simultaneous increase in GFR and enhanced urinary concentrating capacity (see legends on the
right part of the diagram). In contrast, the factor(s) which might initiate the increase in MTAL function and size are not yet well established. A decrease
in water and sodium chloride reabsorption in the pars recta could increase solute delivery to the ascending branch of the loop and thus induce a
load-dependent increase in MTAL transport (see legends on the left part of the diagram). This reduction in proximal reabsorption could result from
the addition of urea into the lumen of the pars recta (dark arrows) due, for the concentration-(ADH)-dependent effect, to urea recycling, and for the
protein-dependent effect, to the (probably indirect) action of glucagon on the pars recta (see text).
entire TAL uniformly. They are restricted to the medullary TAL
and are most pronounced in the earliest part of this segment.
Since, however, both the medullary and the cortical portions of
the TAL exhibit ADH- and glucagon-sensitive adenylate cyclase
and sodium transport [28, 112, 123], the unique pattern of TAL
hypertrophy clearly points to a load-dependent process rather
than to a hormonally-mediated influence.
Increased solute delivety to the TAL
If an increased load to the MTAL seems the most probable
cause of the increased function and hypertrophy of this segment,
the next, yet unresolved question concerns the mechanism by
which this load is increased. Studies in humans have shown that
proximal reabsorption is reduced, and thus delivery to the loop of
Henle increased after a protein meal [124, 125]. Could proximal
reabsorption be decreased and sodium chloride delivery to the
TAL increased in a similar fashion in response to either protein
intake or stimulation of urinary concentrating processes by ADH?
What could be the mechanism responsible for the diminished
proximal reabsorption in each situation?
In the case of a protein meal, glucagon could be involved since
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this hormone has recently been shown to reduce proximal reab-
sorption [99, 126]. Because glucagon does not stimulate adenylate
cyclase activity in the proximal tubule and does not seem to
possess specific receptors in this nephron segment [127, 128], its
effect on the proximal tubule is probably indirect and could result
from glucagon's prior action on the liver. In this organ, glucagon
stimulates cAMP synthesis and release into the circulation [129—
132]. In the kidney, in addition to being filtered, part of this cAMP
is secreted by the organic acid transport system of the proximal
tubule [133]. This nucleotide has been shown to compete with
PAH for accumulation in proximal tubule suspensions [134, 135].
The resulting increase in intracellular concentration of cAMP
seems responsible for the PTH-like effects of glucagon [114, 136].
The fact that the decrease in proximal reabsorption is not rapidly
reversible upon cessation of glucagon infusion in rats (M. Ahlou-
lay and L. Bankir, unpublished results) and is mimicked by an i.v.
infusion of exogenous cAMP speaks in favor of this indirect
mechanism [137] (see discussion in [99]).
In the case of the stimulation of urinary concentration, a
reduction in proximal reabsorption has not been documented to
our knowledge. However, several factors which could possibly be
thought to induce a fall in proximal reabsorption are indeed
modified during sustained high urinary concentration. First, a
60% increase in plasma cAMP concentration has been reported in
normal subjects and patients receiving an infusion of dDAVP
[138]. Although the origin of this increase is not yet well under-
stood, it might increase secretion of cAMP in proximal tubular
cells and thus induce a PTH-like effect, as explained above for
glucagon.
Second, vasopressin or dDAVP favor an intense urea recycling.
It is usually considered that the reintroduction of recycled urea
from the ascending vasa recta to the descending branch of the
loop takes place in the thin descending limbs of short looped-
nephrons [59, 139] which, at least in rodents, run close to or within
the vascular bundles in the inner stripe of the outer medulla [140,
141] and exhibit a relatively high permeability to urea [142].
Although less often mentioned, it is likely that additional urea
could also be reintroduced upstream in the nephron, that is, in the
medullary portion of the pars recta, in the outer stripe. This
assumption is justified by the vascular-tubular relationships pre-
vailing in this area. Medullary pars recta are surrounded by large,
fenestrated vasa recta ascending from deeper regions of the
medulla, and thus heavily loaded with urea [16, 141, 143, 144].
Most likely, a significant concentration gradient favors the diffu-
sion of urea from ascending vasa recta to descending pars recta.
Passive [145, 146] or active [147] urea secretion was observed in
the isolated perfused rabbit pars recta. More recently, some
evidence for urea secretion has been obtained in dog and humans
by the use of pharmacological agents [148—150]. As suggested by
the study of Mudge, Foulks and Oilman [151], the addition of urea
in the proximal tubule lumen could result in an equivalent
reduction of net fluid and solute reabsorption by an osmotic effect,
as does the addition of secreted organic acids [152].
In summary, an enhanced secretion of recycled urea in the pars
recta (in the case of vasopressin), or a glucagon (liver)-dependent
increase in intracellular cAMP (in the case of proteins) could
reduce proximal reabsorption and thus increase delivery of fluid
and solutes to the thick ascending limbs, the common event
thought to be involved in the concentration- and protein-depen-
dent changes in GFR and kidney hypertrophy (Fig. 9).
Functional consequences in health and disease
Because absolute urinary osmolality declines in CRF, it is
generally considered that concentrating ability is impaired. How-
ever, since overall renal function is also impaired, the concentrat-
ing ability of the kidney in CRF is maintained as well as or even
better than the filtration rate when evaluated as solute-free water
reabsorption per unit GFR [153—155]. In a population of 116
outpatients with various primary renal diseases, we observed that,
contrary to the usual belief, urine osmolality declines only slowly
with progression of CRF. Average daily urine osmolality re-
mained hypertonic over most of the progression until creatinine
clearance fell to only 25 ml/min, demonstrating far from neg-
ligeable residual concentrating activity. On the other hand, vaso-
pressin tends to increase with declining renal function [156, 157].
As reviewed in the first section, vasopressin and the stimulation
of urinary concentrating activity tend to increase GFR. Since this
concentrating capacity remains significant in the diseased kidney,
and since vasopressin plasma level tends to increase, vasopressin
probably contributes to inducing compensatory hyperfiltration in
remnant nephrons or, when their individual filtration has reached
its maximum, to unnecessarily enhancing glomerular pressure,
thus accelerating the deterioration of these nephrons.
Given the effectiveness of a reduction in protein intake in
slowing the progression of chronic renal failure (CRF), since, as
reviewed above, dietary proteins influence renal function and
morphology by stimulating the concentrating activity of the kid-
ney, and since this concentrating activity alone tends to increase
GFR, it is logical to asssume that a reduction in the concentrating
activity by itself, that is, independent of any change in protein
intake, could also be beneficial in slowing progression. This is
indeed confirmed or strongly suggested by several observations.
(1) In Sprague Dawley rats with 5/6 nephrectomy, Bouby et al
reduced urinary concentrating activity by increasing water intake
(mixing their food with a water-rich agar gel). As expected,
urinary osmolality and plasma vasopressin concentration fell in
these rats. Proteinuria, systemic blood pressure (Fig. 10), kidney
hypertrophy, incidence of glomerulosclerosis, and mortality [3]
were all significantly reduced by this protocol, thus suggesting that
the activity developed by the kidney for concentrating urinary
solutes contributes to the progressive deterioration of remnant
nephrons. Conversely, proteinuria and mortality were both agravated
in 5/6 nephrectomized Brattleboro DI rats when they received a
constant infusion of the antidiuretic, non-pressor vasopressin ana-
logue dDAVP [158]. In addition, Brattleboro rats with DI show
significantly less hyperifitration in remnant nephrons than do rats
without DI [159].
(2) Chronic renal failure is known to be a major cause of death
in laboratory rats. These rats eat dry pellets throughout their
lifetimes. Several studies have shown that, on a dry food regimen,
water intake, although higher than on a more hydrated regimen,
does not entirely compensate for the low water content of the
food because of a shift in the thirst threshold [160, 1611. It is thus
conceivable that chronic stimulation of urinary concentrating
activity, imposing sustained hyperfiltration throughout life, con-
tributes to the high incidence of CRF in aging laboratory rats.
Actually, one report suggests that longevity is increased in rats fed
hydrated diets [162].
(3) A high protein intake was reported not to aggravate
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progression in rats with lithium-induced CRF [1631. This protec-
tion might be explained by the fact that lithium inhibits the action
of ADH on the collecting ducts [1641 and thus compromises
urinary concentrating capacity and vasopressin-dependent urea
recycling.
(4) It has recently been shown that parathyroidectomy reverses
the deleterious effects of high protein intake in rats with reduced
renal mass [165]. Although not discussed by the authors, it is
logical to assume that the protective effect of parathyroidectomy
could be linked to the significant potentiation of urinary concen-
No reprints are available.
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tration by PTH [166]. Although urinary flow rate and/or osmola-
lity were not available, the marked reduction in kidney weight
seen in parathyroidectomized rats [165] is reminiscent of the low
kidney weight observed in animals in which urinary concentration
is impaired (Tables 1 and 3) [2, 158].
(5) The last piece of evidence supporting the role of urinary
concentration in progression concerns ammonia. Ammonia, one
of the end products of protein metabolism is very toxic and its
plasma level remains very low (50 imol/liter). Thus, an efficient
system is required for enabling its concentration in the urine. This
concentration is achieved by an active secretion and a complex
medullary recycling that prevents ammonia, synthesized and
secreted in the proximal tubules, to leak from the cortical parts of
the distal nephron. Interestingly, Nath, Hostetter and Hostetter
observed a marked reduction of progression of CRF when
ammonia excretion, and thus its urinary concentration, was re-
duced by chronic bicarbonate supplementation [167].
These observations in experimental models of CRF suggest that
a chronic increase in fluid intake or the administration of specific
vasopressin V2 antagonists [1681 could have a beneficial influence
in patients during the early phase of the disease when they still
produce hypertonic urine [156]. The objective would be to reduce
the natural tendency to concentrate urine so as to bring urine
osmolality close to isotonicity. Excessive water intake would of
course challenge the kidney with another undesirable burden, that
of producing dilute urine in order to excrete unappropriate water
loads.
In summary, convergent information suggests that the func-
tional steps involved in concentrating solutes in the urine repre-
sent a burden for the diseased kidney. Reducing either the
amount of solutes to be concentrated (by reducing protein intake)
or reducing the concentrating effort (by providing more fluid for
the excretion of an unchanged amount of solutes) are two
independent and probably additive ways to minimize this burden.
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Fig. 10. Influence of urinaiy concentrating activity on progression of chronic
renal failure. Sprague-Dawley rats with 5/6 nephrectomy were given for 10
weeks an increased water intake by mixing their food with a water-rich
agar gel (0, HWI) and were compared to rats with similar initial renal
impairment but normal water intake (•, NWI). The time-dependent
increases in both proteinuria and blood pressure were markedly reduced
by the reduction of the urinary concentrating activity (average urinary
osmolality was 390 9 in HWI vs 946 122 in NWI). On the sixth week
of the study, 3 NWI rats (of the initial 9) died from advanced renal failure
and the 3 corresponding HWI rats were sacrified (shown by 3t). Adapted
from [3]; used with permission.
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Appendix. Abbreviations
ADH antiduretic hormone, vasopressin
AVP arginine-vasopressin
CD collecting duct
CRF chronic renal failure
Bankir and Kriz: Protein intake and urinaty concentration 21
1 deamino 8-D-arginine vasopressin
diabetes insipidus
fractional excretion of urea
glomerular filtration rate
inner stripe of the outer medulla
medullary and cortical parts of the TAL
papillary plasma flow rate
single nephron glomerular filtration rate
thick ascending limb of Henle's loop
free water reabsorption
tubuloglomerular feedback
Note added in proof
Several observations pertinent to the questions discussed in this review
have become available recently. (1) Infusion of dDAVP (an antidiuretic
analogue of ADH devoid of vascular action) has been shown to increase
renal plasma flow in humans [169]. It is interesting to note that, in this
study, subjects were not submitted to water diuresis prior to dDAVP
infusion, thus probably preventing the volume expansion and/or plasma
dilution induced by massive water intake as occurred in many previous
studies. (2) The marked and preferential hypertrophy (and hyperplasia) of
the MTAL observed in the hypertrophied kidney after high protein intake
might be triggered by insulin-like growth factor I (IGF-1), a hormone for
which a high density of receptors is selectively found in this nephron
segment. The gene expression of IGF-1 receptor in the MTAL was
markedly increased, and that of IGF binding protein (reducing IGF-1
availability for binding to its specific receptors) decreased after 2 to 7 days
of high protein intake in rats [170]. However, as stated by the authors, the
stimulus initiating these changes is still unknown. Intriguingly, in the same
study, high protein intake in Brattleboro rats with DI (40% vs. 18% casein
diet for 4 days) was found to induce a normal hypertrophy of the kidney
[170] in contrast to the results of Bouby et al (32% vs. 10% casein diet for
7 weeks) [102]. (3) Patients with diabetes insipidus were found to have a
lower GRF than control subjects, as previously observed in Brattleboro DI
rats. They, nevertheless, exhibited a normal rise a GFR after a protein
meal [171].
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